Delivery Order SPE2DE24DA010-SPE2D625F51QH

Award Date 1/30/25
Potential Completion Date 2/4/25
Potential Value $30K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a Delivery Order for cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The award has a fixed-price with economic price adjustment pricing type and a completion...
This federal contract award, valued at $1,680.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract is not associated with a set-aside designation, indicating full and open competition....
This federal contract award, valued at $25,715.85, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the provision of cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. Abbott Laboratories Inc. is a large, multinational pharmaceutical and medical device...
This is a delivery order contract awarded by the Department of Defense's Medical Supply Chain agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $32,904.70 fixed-price with economic price adjustment contract has a completion date of February 10, 2025. The award is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, and related surgical implants designed to support complex medical procedures and improve patient...
This is a $14,498.00 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., specifically through its Abbott Vascular Inc. division. The contract is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The award is a fixed-price delivery order contract with economic price adjustment and does not have a set-aside designation, indicating full and open competition. The contract covers the delivery of a range of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer. The $28,350.00 fixed-price contract with economic price adjustment is for the delivery of various cardiovascular medical devices and systems, including stents, pacemakers, heart valves, and implantable cardiac monitors. These products will support the healthcare needs of veterans at Department of Veterans Affairs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical unit to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the amount of $30,281.95. The order is for a variety of medical devices and supplies, including cardiovascular products like stents, pacemakers, heart valves, and implantable cardiac monitors, as well as specialized equipment like catheter labs and mapping systems. The contract has a fixed price with economic...
This federal contract award, valued at $38,014.80, was issued by the Medical Supply Chain division of the Defense Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The delivery order contract is for fixed-price provision of cardiovascular medical devices, with economic price adjustment, and has a completion date of January 29, 2025. No set-aside designation was used, indicating full and open competition. Abbott Laboratories Inc. is a large, multinational medical...
This federal contract award, valued at $33,000.00, was issued by the Defense Health Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a period of performance through February 2025. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories is a major manufacturer of cardiovascular medical devices, including stents, pacemakers, heart...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F51QH
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), an organization under the Department of Defense (DoD), to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract, valued at $30,281.95, is for the delivery of cardiovascular medical devices and related supplies, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a period of performance ending on February 4, 2025, and uses a fixed price with economic price adjustment pricing type. This contract award is not designated as a set-aside. Abbott Laboratories Inc., a global healthcare company, has been a significant federal contractor, particularly within the healthcare and medical supply sectors, providing a wide range of critical medical products to federal agencies such as the Department of Veterans Affairs (VA) and the DLA. The company has secured several notable Indefinite Delivery Contracts (IDCs) with these agencies, demonstrating its strategic importance in providing comprehensive cardiovascular medical solutions, including devices, instrumentation, and technical support services.

Generated 5/1/25, 9:57 AM